ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0396

Validity of Syndesmophyte Detection on Low Dose Computed Tomography in Patients with Radiographic Axial Spondyloarthritis

Rosalinde Stal1, Sofia Ramiro1, Xenofon Baraliakos2, Juergen Braun3, Monique Reijnierse1, Rosaline van den Berg1, floris van Gaalen1 and Désirée van der Heijde4, 1Leiden University Medical Center, Leiden, Netherlands, 2Rheumazentrum Ruhrgebiet Herne, Herne, Germany, 3Rheumazentrum Ruhrgebiet, Herne, Germany, 4Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands, Leiden, Netherlands

Meeting: ACR Convergence 2022

Keywords: Ankylosing spondylitis (AS), Computed tomography (CT), X-ray

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, and Outcomes Poster I

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Low-dose Computed Tomography (ldCT), assessed with the CT syndesmophyte score (CTSS) in the whole spine, has been shown to detect more progression in the form of new and growing syndesmophytes than the current gold standard, which is conventional radiography (CR) assessed with the modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS). However, the validity of ldCT detected syndesmophytes has not been analyzed. We assessed the convergent validity of ldCT detected syndesmophytes by evaluating whether syndesmophytes on ldCT were also seen on CR at the same vertebral corner (VC) at the same timepoint or two years later.

Methods: Patients from the Sensitive Imaging in Ankylosing Spondylitis cohort underwent ldCT at baseline and CR at baseline and two years. Images were assessed by two (ldCT) or three (CR) readers. While ldCT is able to assess the whole spine and multiple corners per vertebra, in the current study only corners assessed on both modalities by all readers were included to allow for comparison of the two modalities at the VC level. Thus, scores from 12 anterior cervical and 12 anterior lumbar corners were included for each modality. Syndesmophyte presence on ldCT at baseline, regardless of size, was defined per reader and per VC. Syndesmophyte presence on CR, regardless of size, was coded binary as present if seen at baseline, 2 years or both timepoints, per reader per VC. For each reader pair, the number of corners with a syndesmophyte on ldCT at baseline is given, together with the proportion of these corners that also had a syndesmophyte on CR at baseline or 2 years.

Results: In total 48 patients (85% male, 85% HLA-B27+, mean age 48.3 (SD 9.8) years) had complete imaging and scores, contributing 917 corners per timepoint. At baseline, syndesmophytes were seen on ldCT in 348 (38%, reader 1) and 327 (36%, reader 2) corners out of 917. The figure shows the proportions of corners where a syndesmophyte was also seen on CR at baseline or 2 years per CR reader (62%-79%), and the proportion of corners where a syndesmophyte was only seen on ldCT (21%-38%).

Conclusion: Approximately three quarters of the syndesmophytes visible on ldCT is also visible on the same VC on CR at the same timepoint or two years later. This shows that syndesmophytes on ldCT are also identified as a syndesmophyte on CR on the same VC and adds to the convergent validity of ldCT for the measurement of structural damage in axSpA. Studies with longer follow-up may address whether ldCT syndesmophytes not seen on CR 2 years later can be detected on CR at a later stage.

Supporting image 1

Figure: Syndesmophytes visible on low dose Computed Tomography and those also visible on conventional radiography at baseline or 2 years later
The figure displays the corners with a syndesmophyte on low dose CT (reader 1: 348, reader 2: 327) and the proportion of those corners also visible on CR at baseline or 2 years. Results are presented per reader pair. LdCT, low-dose Computed Tomography; BL, baseline; 2y, 2 years.


Disclosures: R. Stal, None; S. Ramiro, AbbVie/Abbott, Eli Lilly, Galapagos, Merck/MSD, Novartis, Pfizer, UCB, Sanofi; X. Baraliakos, AbbVie, Lilly, Galapagos, MSD, Novartis, Pfizer, UCB, Bristol-Myers Squibb, Janssen, Roche, Sandoz, Sanofi; J. Braun, None; M. Reijnierse, ASAS, International Skeletal Society; R. van den Berg, None; f. van Gaalen, Stichting vrienden van Sole Mio, Stichting ASAS, Jacobus stichting, Novartis, UCB, MSD, AbbVie, Bristol Myers Squibb, Eli Lilly; D. van der Heijde, AbbVie, Bayer, BMS, Cyxone, Eisai, Galapagos, Gilead, Glaxo-Smith-Kline, Janssen, Novartis, Pfizer, UCB, Imaging Rheumatology bv, Lilly.

To cite this abstract in AMA style:

Stal R, Ramiro S, Baraliakos X, Braun J, Reijnierse M, van den Berg R, van Gaalen f, van der Heijde D. Validity of Syndesmophyte Detection on Low Dose Computed Tomography in Patients with Radiographic Axial Spondyloarthritis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/validity-of-syndesmophyte-detection-on-low-dose-computed-tomography-in-patients-with-radiographic-axial-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/validity-of-syndesmophyte-detection-on-low-dose-computed-tomography-in-patients-with-radiographic-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology